Lyell Immunopharma (LYEL) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 8:00 A.M. Pacific on June 10, 2026, via a virtual platform, with introductions of the Board, executive team, and key advisors.

• The agenda included three proposals: election of directors, ratification of auditors, and an advisory vote on executive compensation.

Board and executive committee updates

• Board members and executive team were introduced, including roles such as CEO, CFO, COO, General Counsel, and Chief Scientific Officer.

Shareholder proposals

• No stockholder nominations for director positions were submitted in advance as required by bylaws.